Skip to main content

Table 1 Baseline demographic and clinical characteristics of patients who had pulmonary tuberculoma or non-tuberculous pulmonary diseases

From: EBUS-GS with the GeneXpert MTB/RIF assay for diagnosis of Mycobacterium tuberculosis infection of isolated pulmonary nodules

Characteristic

Number of cases n = 135

TB group n = 64

Non-TB group n = 71

P-value

Age (years)

55.80 ± 14.07

53.80 ± 15.09

57.61 ± 12.92

0.117

Gender (n, %)

 Male

95 (70.37%)

43 (67.19%)

52 (73.24%)

0.442

 Female

40 (29.63%)

21 (32.81%)

19 (26.76%)

BMI (kg/m2)

21.35 ± 3.65

21.24 ± 3.73

21.81 ± 3.58

0.740

Smoking (n, %)

48 (35.56%)

27 (42.19%)

21 (29.58%)

0.126

Diadetes (n, %)

27 (20.00%)

17 (26.56%)

10 (14.08%)

0.070

Symptoms (n, %)

 Cough

63 (46.67%)

29 (45.31%)

34 (47.89%)

0.765

 Chest pain

12 (8.89%)

6 (9.38%)

6 (8.45%)

0.851

 Hemoptysis

15 (11.11%)

4 (6.25%)

11 (15.49%)

0.088

 Fever

12 (8.89%)

5 (7.81%)

7 (9.86%)

0.677

 No symptoms

44 (32.59%)

21 (32.81%)

23 (32.39%)

0.959

QFT (n, %)

 Positive

93 (68.89%)

58 (90.63%)

35 (49.30%)

 < 0.001

 Negative

42 (31.11%)

6 (9.38%)

36 (50.70%)

Lesion size (n, %)

 1–2 cm

53 (39.26%)

22 (34.38%)

31 (43.66%)

0.270

 2–3 cm

82 (60.74%)

42 (65.62%)

40 (56.34%)

Lesion location (n, %)

 Right upper lobe

51 (37.77%)

26 (40.63%)

25 (35.21%)

0.534

 Right middle lobe

12 (8.89%)

5 (7.81%)

7 (9.86%)

 Right inferior lobe

25 (18.53%)

9 (14.06%)

16 (22.54%)

 Left upper lobe

31 (22.96%)

14 (21.87%)

17 (23.94%)

 Left inferior lobe

16 (11.85%)

10 (15.63%)

6 (8.45%)

  1. BMI body mass index; QFT QuantiFERON-TB Gold In-Tube test